BIOMAT Database Logo BIOMAT Database Logo

[Cycloergometric evaluation of fendiline in chronic coronary insufficiency]. 1979

D Armaganijan, and M Batlouni, and J R de Araújo

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions

Related Publications

D Armaganijan, and M Batlouni, and J R de Araújo
[Fendiline hydrochloride as a therapeutic agent in chronic coronary insufficiency].
April 1980, Arquivos brasileiros de cardiologia,
D Armaganijan, and M Batlouni, and J R de Araújo
[Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
February 1977, Arquivos brasileiros de cardiologia,
D Armaganijan, and M Batlouni, and J R de Araújo
[Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
August 1982, Arquivos brasileiros de cardiologia,
D Armaganijan, and M Batlouni, and J R de Araújo
[The cycloergometric exercise test in the radiotelemetric diagnosis of coronary insufficiency].
June 1979, Minerva medica,
D Armaganijan, and M Batlouni, and J R de Araújo
[Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
February 1978, Arquivos brasileiros de cardiologia,
D Armaganijan, and M Batlouni, and J R de Araújo
[Clinical evaluation of fendiline as a coronary drug].
February 1988, Polski tygodnik lekarski (Warsaw, Poland : 1960),
D Armaganijan, and M Batlouni, and J R de Araújo
[Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
February 1978, Arquivos brasileiros de cardiologia,
D Armaganijan, and M Batlouni, and J R de Araújo
[Association of the cycloergometric test, pharmacological tests and autonomic maneuvers in the diagnosis of coronary insufficiency].
April 1977, Recenti progressi in medicina,
D Armaganijan, and M Batlouni, and J R de Araújo
[Temporary disability evaluation in chronic coronary insufficiency (angina pectoris)].
November 1976, Sovetskaia meditsina,
D Armaganijan, and M Batlouni, and J R de Araújo
[Chronic coronary insufficiency].
June 1972, Fel'dsher i akusherka,
Copied contents to your clipboard!